NRX Pharmaceuticals, Inc.
Pharmaceutical company · Wilmington, Delaware, United States · Nasdaq: NRXP
NRX Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Wilmington, Delaware, United States. Its shares trade on Nasdaq under the ticker NRXP. It has reported private securities offerings to the US SEC, most recently $3.5 million sold in a notice filed in 2025.
NRX Pharmaceuticals at a glance
What does NRX Pharmaceuticals do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $3.5 million sold (2025).
Frequently asked questions about NRX Pharmaceuticals
Where is NRX Pharmaceuticals headquartered?
NRX Pharmaceuticals, Inc. is headquartered in Wilmington, Delaware, United States.
What does NRX Pharmaceuticals do?
NRX Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is NRX Pharmaceuticals a public company?
Yes. NRX Pharmaceuticals, Inc. trades on Nasdaq under the ticker NRXP.
Similar companies
- Prelude Therapeutics IncWilmington, Delaware, United States
- Dusa Pharmaceuticals IncWilmington, Massachusetts, United States
- NeuroRx, Inc.Wilmington, Delaware, United States
- Applied Molecular Transport Inc.Wilmington, Delaware, United States
- ImmunoRx Pharma, Inc.Wilmington, Delaware, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences